These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651 [TBL] [Abstract][Full Text] [Related]
3. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression. Hofmann S; Grasberger H; Jung P; Bidlingmaier M; Vlotides J; Janssen OE; Landgraf R Eur J Med Res; 2002 Apr; 7(4):171-6. PubMed ID: 12010652 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation. Friedl J; Turner E; Alexander HR Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895 [TBL] [Abstract][Full Text] [Related]
5. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo. Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236 [TBL] [Abstract][Full Text] [Related]
6. Exposing endothelial cells to tumor necrosis factor-α and peripheral blood mononuclear cells damage endothelial integrity via interleukin-1ß by degradation of vascular endothelial-cadherin. Seynhaeve AL; Rens JA; Schipper D; Eggermont AM; Ten Hagen TL Surgery; 2014 Mar; 155(3):545-53. PubMed ID: 24439748 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial cadherin expression in lung specimens of patients with sepsis-induced acute respiratory distress syndrome and endothelial cell cultures. Herwig MC; Tsokos M; Hermanns MI; Kirkpatrick CJ; Müller AM Pathobiology; 2013; 80(5):245-51. PubMed ID: 23635392 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin. Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592 [TBL] [Abstract][Full Text] [Related]
9. A human melanoma xenograft in a nude rat responds to isolated limb perfusion with TNF plus melphalan. Bauer TW; Gutierrez M; Dudrick DJ; Li J; Blair IA; Menon C; Fraker DL Surgery; 2003 Apr; 133(4):420-8. PubMed ID: 12717360 [TBL] [Abstract][Full Text] [Related]
10. Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling. Vincent L; Kermani P; Young LM; Cheng J; Zhang F; Shido K; Lam G; Bompais-Vincent H; Zhu Z; Hicklin DJ; Bohlen P; Chaplin DJ; May C; Rafii S J Clin Invest; 2005 Nov; 115(11):2992-3006. PubMed ID: 16224539 [TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium. Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935 [TBL] [Abstract][Full Text] [Related]
13. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavage. Sidibé A; Mannic T; Arboleas M; Subileau M; Gulino-Debrac D; Bouillet L; Jan M; Vandhuick T; Le Loët X; Vittecoq O; Vilgrain I Arthritis Rheum; 2012 Jan; 64(1):77-87. PubMed ID: 21905018 [TBL] [Abstract][Full Text] [Related]
14. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells. Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345 [TBL] [Abstract][Full Text] [Related]
15. Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown. Zhang P; Feng S; Liu G; Wang H; Zhu H; Ren Q; Bai H; Fu C; Dong C J Biol Chem; 2016 Jan; 291(5):2087-106. PubMed ID: 26504080 [TBL] [Abstract][Full Text] [Related]
16. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus. Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523 [TBL] [Abstract][Full Text] [Related]
17. Interference With ESAM (Endothelial Cell-Selective Adhesion Molecule) Plus Vascular Endothelial-Cadherin Causes Immediate Lethality and Lung-Specific Blood Coagulation. Duong CN; Nottebaum AF; Butz S; Volkery S; Zeuschner D; Stehling M; Vestweber D Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):378-393. PubMed ID: 31826650 [TBL] [Abstract][Full Text] [Related]
18. Role of cadherins in the transendothelial migration of melanoma cells in culture. Sandig M; Voura EB; Kalnins VI; Siu CH Cell Motil Cytoskeleton; 1997; 38(4):351-64. PubMed ID: 9415377 [TBL] [Abstract][Full Text] [Related]
19. Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin Internalization. Lei X; Chen M; Huang M; Li X; Shi C; Zhang D; Luo L; Zhang Y; Ma N; Chen H; Liang H; Ye W; Zhang D Theranostics; 2018; 8(2):384-398. PubMed ID: 29290815 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling. Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]